These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29388481)

  • 1. Chemotherapy alters the increased numbers of myeloid-derived suppressor and regulatory T cells in children with acute lymphoblastic leukemia.
    Salem ML; El-Shanshory MR; Abdou SH; Attia MS; Sobhy SM; Zidan MF; Zidan AA
    Immunopharmacol Immunotoxicol; 2018 Apr; 40(2):158-167. PubMed ID: 29388481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid-derived suppressor cells and regulatory T cells share common immunoregulatory pathways-related microRNAs that are dysregulated by acute lymphoblastic leukemia and chemotherapy.
    Labib Salem M; Zidan AA; Ezz El-Din El-Naggar R; Attia Saad M; El-Shanshory M; Bakry U; Zidan M
    Hum Immunol; 2021 Jan; 82(1):36-45. PubMed ID: 33162185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in polymorphonuclear myeloid-derived suppressor cells and regulatory T-cells in children with B-cell acute lymphoblastic leukemia.
    Zahran AM; Shibl A; Rayan A; Mohamed MAEH; Osman AMM; Saad K; Mahmoud KH; Ghandour AMA; Elsayh KI; El-Badawy O
    Sci Rep; 2021 Jul; 11(1):15039. PubMed ID: 34294814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial-to-mesenchymal Transition Heterogeneity of Circulating Tumor Cells and Their Correlation With MDSCs and Tregs in HER2-negative Metastatic Breast Cancer Patients.
    Papadaki MA; Aggouraki D; Vetsika EK; Xenidis N; Kallergi G; Kotsakis A; Georgoulias V
    Anticancer Res; 2021 Feb; 41(2):661-670. PubMed ID: 33517270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-α-based treatment of patients with chronic HCV show increased levels of cells with myeloid-derived suppressor cell phenotype and of IDO and NOS.
    Salem ML; Zidan AA; Attia M; El-Naggar RE; Nassef M; Abou El-Azm AR; El-Bate H; Yussif M; Galal S; Abo Senna M; El Demellawy M
    Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):188-198. PubMed ID: 28472907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgery-induced monocytic myeloid-derived suppressor cells expand regulatory T cells in lung cancer.
    Wang J; Yang L; Yu L; Wang YY; Chen R; Qian J; Hong ZP; Su XS
    Oncotarget; 2017 Mar; 8(10):17050-17058. PubMed ID: 28178645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocytic myeloid-derived suppressor cells maintain feto-maternal tolerance by inducing Foxp3 expression in CD4+CD25-T cells by activation of the TGF-β/β-catenin pathway.
    Kang X; Zhang X; Liu Z; Xu H; Wang T; He L; Zhao A
    Mol Hum Reprod; 2016 Jul; 22(7):499-511. PubMed ID: 27016139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients.
    Choi HS; Ha SY; Kim HM; Ahn SM; Kang MS; Kim KM; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kang ES
    Oncotarget; 2016 Feb; 7(7):7940-51. PubMed ID: 26799288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical association of programmed death-1/PD-L1 axis, myeloid derived suppressor cells subsets and regulatory T cells in peripheral blood of stable COPD patients.
    Zhang M; Wan Y; Han J; Li J; Gong H; Mu X
    PeerJ; 2024; 12():e16988. PubMed ID: 38560459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway.
    Ren JP; Zhao J; Dai J; Griffin JW; Wang L; Wu XY; Morrison ZD; Li GY; El Gazzar M; Ning SB; Moorman JP; Yao ZQ
    Immunology; 2016 Aug; 148(4):377-86. PubMed ID: 27149428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering the Crosstalk Between Myeloid-Derived Suppressor Cells and Regulatory T Cells in Pancreatic Ductal Adenocarcinoma.
    Siret C; Collignon A; Silvy F; Robert S; Cheyrol T; André P; Rigot V; Iovanna J; van de Pavert S; Lombardo D; Mas E; Martirosyan A
    Front Immunol; 2019; 10():3070. PubMed ID: 32038621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Th17 and CD4
    Xiang M; Guo L; Ma Y; Li Y
    Pak J Pharm Sci; 2016 Nov; 29(6 Suppl):2405-2410. PubMed ID: 28167485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T Cells and Myeloid-Derived Suppressor Cells in Patients with Peptic Ulcer and Gastric Cancer.
    Mesali H; Ajami A; Hussein-Nattaj H; Rafiei A; Rajabian Z; Asgarian-Omran H; Hosseini V; Taghvaei T; Tehrani M
    Iran J Immunol; 2016 Sep; 13(3):167-77. PubMed ID: 27671508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased regulatory T cells in acute lymphoblastic leukemia patients.
    Idris SZ; Hassan N; Lee LJ; Md Noor S; Osman R; Abdul-Jalil M; Nordin AJ; Abdullah M
    Hematology; 2015 Oct; 20(9):523-9. PubMed ID: 26119924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes of Peripheral Blood Marrow-Derived Suppressor Cell Level after Chemotherapy Induction Remission by VDLP Regimen and Their Relationship with Immune System in B-ALL Children].
    Guo XM; Fang YJ; Lv CL; Wang YR; Sun XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1611-1614. PubMed ID: 29262884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial.
    Jiménez-Cortegana C; Palazón-Carrión N; Martin Garcia-Sancho A; Nogales-Fernandez E; Carnicero-González F; Ríos-Herranz E; de la Cruz-Vicente F; Rodríguez-García G; Fernández-Álvarez R; Rueda Dominguez A; Casanova-Espinosa M; Martínez-Banaclocha N; Gumà-Padrò J; Gómez-Codina J; Labrador J; Salar-Silvestre A; Rodriguez-Abreu D; Galvez-Carvajal L; Provencio M; Sánchez-Beato M; Guirado-Risueño M; Espejo-García P; Lejeune M; Álvaro T; Sánchez-Margalet V; de la Cruz-Merino L; ; ;
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34158317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid-derived suppressor cells: The green light for myeloma immune escape.
    Malek E; de Lima M; Letterio JJ; Kim BG; Finke JH; Driscoll JJ; Giralt SA
    Blood Rev; 2016 Sep; 30(5):341-8. PubMed ID: 27132116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recruitment of myeloid‑derived suppressor cells and regulatory T‑cells is associated with the occurrence of acute myocardial infarction.
    Zhang M; Shi X; Zhao J; Guo W; Zhou J
    Biomed Rep; 2023 Aug; 19(2):55. PubMed ID: 37560314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury.
    Zhang C; Wang S; Li J; Zhang W; Zheng L; Yang C; Zhu T; Rong R
    Cell Death Dis; 2017 Mar; 8(3):e2695. PubMed ID: 28333137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of CD4
    Wang J; Yang J
    Biomed Rep; 2016 Aug; 5(2):208-212. PubMed ID: 27446543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.